Evidence map›Paper›PMID 41286512›Full record

ArticleBone marrow transplantation2026

Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia.

Rasha W Al-Ali, Gege Gui, Niveditha Ravindra, Georgia Andrew, Devdeep Mukherjee, Zoë C Wong, Ying Huang, Jason Gerhold, Matt Holman, Austin Jacobsen and 18 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Bone marrow transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Two Decades ofCancers · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Rasha W Al-Ali *Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, DC, USA.
Gege Gui *Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, DC, USA.
Niveditha RavindraLaboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-2550-493X
Georgia AndrewLaboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Devdeep MukherjeeLaboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Zoë C WongLaboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Ying HuangInvivoscribe, Inc, San Diego, CA, USA.
Jason GerholdInvivoscribe, Inc, San Diego, CA, USA.
Matt HolmanInvivoscribe, Inc, San Diego, CA, USA.
Austin JacobsenInvivoscribe, Inc, San Diego, CA, USA.
Julian D'AngeloInvivoscribe, Inc, San Diego, CA, USA.
Jeffrey MillerInvivoscribe, Inc, San Diego, CA, USA.
Karina EliasInvivoscribe, Inc, San Diego, CA, USA.
Jeffery J AulettaCenter for International Blood and Marrow Transplant Research, NMDP, Minneapolis, MN, USA.ORCID http://orcid.org/0000-0002-1515-2141
Firas El ChaerUniversity of Virginia, Charlottesville, VA, USA.ORCID http://orcid.org/0000-0001-9596-0714
Steven M DevineCenter for International Blood and Marrow Transplant Research, NMDP, Minneapolis, MN, USA.ORCID http://orcid.org/0000-0001-7731-759X
Antonio Martin Jimenez JimenezSylvester Comprehensive Cancer Center, Miami, FL, USA.ORCID http://orcid.org/0000-0003-2817-6836
Marcos J G De LimaThe Ohio State University College of Medicine, Columbus, OH, USA.ORCID http://orcid.org/0000-0002-8568-4522
Mark R LitzowMayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-9816-6302
Partow KebriaeiThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-8607-9404
Wael SaberCenter for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA.
Stephen R SpellmanCenter for International Blood and Marrow Transplant Research, NMDP, Minneapolis, MN, USA.
Scott L ZegerDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Kristin M PageCenter for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA.
Jerald P RadichFred Hutchinson Cancer Research Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-1618-230X
R Coleman LindsleyDana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Laura W DillonFralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, DC, USA.ORCID http://orcid.org/0000-0002-4877-9354
Christopher S HouriganFralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, DC, USA. hourigan@vt.edu.ORCID http://orcid.org/0000-0002-6189-8067

Funding

Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
NCI NIH HHS U24 CA076518U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) 1-ZIA-HL006163
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41286512
PMCPMC12909118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.